Therapeutics

JAMA Network

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19A Randomized Clinical Trial

JAMA Network

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

 Randomized Clinical Trial

JAMA Network

Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

JAMA Network

Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19The CoDEX Randomized Clinical Trial

JAMA Network

Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19A Randomized Clinical Trial

JAMA Network

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis

JAMA Network

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial

Thrombosis and Haemostasis

Pharmacological Agents Targeting Thromboinflammation in COVID19

JAMA Network

Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19

NEJM

Compassionate Use of Remdesivir for Patients with Severe Covid-19

New England Journal of Medicine

RAAS Inhibitors in COVID-19 Patients

New England Journal of Medicine

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

JAMA Cardiology

Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers

JAMA

Convalescent Plasma to Treat COVID-19: Possibilities and Challenges

JAMA

Management of Critically Ill Adults With COVID-19

JAMA

COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?

Lancet

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.

Lancet

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.

Lancet

Treatment for severe acute respiratory distress syndrome from COVID-19

Annals of Internal Medicine

Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know

Annals of Internal Medicine

A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19

International Journal of Antimicrobial Agents

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

International Journal of Antimicrobial Agents

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.

Bioscience Trends

Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.

Journal of Critical Care

A systematic review on the efficacy and safety of chloroquine for the treatment.

NEJM Journal Watch

Chloroquine and Hydroxychloroquine: Old Drugs in a New COVID-19 World

NEJM

SARS-CoV-2 Testing and Changes in Primary Care Services in a Multistate Network of Community Health Centers During the COVID-19 Pandemic

JAMA Network

COVID19 Vaccines and Therapeutics, Clinical Genomics in Critically Ill Children, and More

JAMA Network

Planning for a COVID19 Vaccination Program

NEJM

Hydrochloroquine as Postexposure Prophylaxis for COVID19

©2020 by COVID19SI.com
Donated and Created by Dr. John Maese, Dr. Donna Seminara, and Dr. Zeel Shah.